Finance

Beta
Lists
CPH:TSE
Cipher Pharmaceuticals Inc
CA$16.52
-1.14%
(-0.19) 1D
Jun 3, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CPH...
Open
CA$16.60
High
CA$16.65
Low
CA$16.51
Mkt. cap
419.46M
Avg. vol.
27.48K
Volume
14.90K
P/E ratio
10.02
52-wk high
CA$20.56
52-wk low
CA$11.98
EPS
CA$1.65
Beta
-0.06
Shares outstanding
25.28M
No. of employees
43
Open
CA$16.60
High
CA$16.65
Low
CA$16.51
Mkt. cap
419.46M
Avg. vol.
27.48K
Volume
14.90K
P/E ratio
10.02
52-wk high
CA$20.56
52-wk low
CA$11.98
EPS
CA$1.65
Beta
-0.06
Shares outstanding
25.28M
No. of employees
43
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to CPH in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for CPH in the last 3 months.
Highest
Current CA$16.52
CA$22.00 (+33.17%)
Average
CA$22.00 (+33.15%)
Lowest
CA$22.00 (+33.17%)
News stories
From sources across the web
About Cipher Pharmaceuticals Inc
CEO-
Employees43
Founded2000
HeadquartersMississauga, Ontario, Canada
SectorPharmaceutical industry
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (CAD)
- / -
Revenue / Est. (CAD)
17.06M / 16.90M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
13.38M
12.83M
12.22M
12.50M
Cost of goods sold
2.50M
2.35M
2.30M
2.21M
Cost of revenue
2.50M
2.35M
2.30M
2.21M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.08M
3.71M
3.68M
2.90M
Operating expense
5.89M
5.51M
5.49M
4.70M
Total operating expenses
8.39M
7.86M
7.79M
6.91M
Operating income
4.99M
4.97M
4.43M
5.60M
Other non operating income
-
-
-
-
EBT including unusual items
6.40M
4.26M
4.61M
4.95M
EBT excluding unusual items
6.40M
4.13M
4.84M
4.89M
Income tax expense
512.00K
-1.24M
-8.70M
-1.21M
Effective tax rate
7.99%
-29.19%
-188.55%
-24.53%
Other operating expenses
-
-
-
-
Net income
5.89M
5.50M
13.31M
6.16M
Net profit margin
44.04%
42.87%
108.95%
49.28%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-345.00K
-241.00K
-109.00K
-51.00K
Net interest expenses
-345.00K
-241.00K
-109.00K
-51.00K
Depreciation and amortization charges
1.81M
1.80M
1.81M
1.81M
EBITDA
6.80M
6.77M
5.95M
7.40M
Gain or loss from assets sale
-
-
-130.00K
-57.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more